Literature DB >> 17657841

Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.

Kei Ito1, Naotaka Fujita, Yutaka Noda, Go Kobayashi, Jun Horaguchi, Osamu Takasawa, Takashi Obana.   

Abstract

AIM: To clarify the relationship between the change of serum amylase level and post-ERCP pancreatitis.
METHODS: Between January 1999 and December 2002, 1291 ERCP-related procedures were performed. Serum amylase concentrations were measured before the procedure and 3, 6, and 24 h afterward. The frequency and severity of post-ERCP pancreatitis and the relationship between these phenomena and the change in amylase level were estimated.
RESULTS: Post-ERCP pancreatitis occurred in 47 patients (3.6%). Pancreatitis occurred in 1% of patients with normal amylase levels 3 h after ERCP, and in 1%, 5%, 20%, 31% and 39% of patients with amylase levels elevated 1-2 times, 2-3 times, 3-5 times, 5-10 times and over 10 times the upper normal limit at 3 h after ERCP, respectively (level < 2 times vs >or= 2 times, P < 0.001). Of the 143 patients with levels higher than the normal limit at 3 h after ERCP followed by elevation at 6 h, pancreatitis occurred in 26%. In contrast, pancreatitis occurred in 9% of 45 patients with a level higher than two times the normal limit at 3 h after ERCP followed by a decrease at 6 h (26% vs 9%, P < 0.05).
CONCLUSION: Post-ERCP pancreatitis is frequently associated with an increase in serum amylase level greater than twice the normal limit at 3 h after ERCP with an elevation at 6 h. A decrease in amylase level at 6 h after ERCP suggests the unlikelihood of development of post-ERCP pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657841      PMCID: PMC4611219          DOI: 10.3748/wjg.v13.i28.3855

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.

Authors:  E Masci; G Toti; A Mariani; S Curioni; A Lomazzi; M Dinelli; G Minoli; C Crosta; U Comin; A Fertitta; A Prada; G R Passoni; P A Testoni
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

2.  Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.

Authors:  Dimitrios Arvanitidis; George K Anagnostopoulos; Dimitrios Giannopoulos; Athanasios Pantes; Roxanne Agaritsi; George Margantinis; Stavros Tsiakos; George Sakorafas; Panagiotis Kostopoulos
Journal:  J Gastroenterol Hepatol       Date:  2004-03       Impact factor: 4.029

3.  Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.

Authors:  R T-P Poon; C Yeung; C-L Liu; C-M Lam; W-K Yuen; C-M Lo; A Tang; S-T Fan
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

4.  Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial.

Authors:  Naotaka Fujita; Hiroyuki Maguchi; Yutaka Komatsu; Ichiro Yasuda; Osamu Hasebe; Yoshinori Igarashi; Akihiko Murakami; Hidekazu Mukai; Tsuneshi Fujii; Kenji Yamao; Kensei Maeshiro
Journal:  Gastrointest Endosc       Date:  2003-02       Impact factor: 9.427

5.  Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.

Authors:  James A Disario; Martin L Freeman; David J Bjorkman; Padraic Macmathuna; Bret T Petersen; Philip E Jaffe; Thomas G Morales; Lee J Hixson; Stuart Sherman; Glen A Lehman; M Mazen Jamal; Firas H Al-Kawas; Mukul Khandelwal; Joseph P Moore; Gregory A Derfus; Priya A Jamidar; Francisco C Ramirez; Michael E Ryan; Karen L Woods; David L Carr-Locke; Stephen C Alder
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.

Authors:  G Cavallini; A Tittobello; L Frulloni; E Masci; A Mariana; V Di Francesco
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

7.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

8.  Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.

Authors:  E Christoforidis; I Goulimaris; I Kanellos; K Tsalis; C Demetriades; D Betsis
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

9.  Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.

Authors:  Angelo Andriulli; Luigi Solmi; Silvano Loperfido; Pietro Leo; Virginia Festa; Angelo Belmonte; Fulvio Spirito; Michele Silla; Giovambattista Forte; Vittorio Terruzzi; Giorgio Marenco; Enrico Ciliberto; Antonio Sabatino; Fabio Monica; Maria Rita Magnolia; Francesco Perri
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

10.  Risk factors for complications after performance of ERCP.

Authors:  Jo Vandervoort; Roy M Soetikno; Tony C K Tham; Richard C K Wong; Angelo P Ferrari; Henry Montes; Alfred D Roston; Adam Slivka; David R Lichtenstein; Frederick W Ruymann; Jacques Van Dam; Mike Hughes; David L Carr-Locke
Journal:  Gastrointest Endosc       Date:  2002-11       Impact factor: 9.427

View more
  12 in total

1.  Serum lipase as a biomarker for early prediction and diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Yu Zhang; Xiaoling Ye; Xinyue Wan; Tao Deng
Journal:  Ir J Med Sci       Date:  2019-08-28       Impact factor: 1.568

2.  Comparative analysis of endoscopic precut conventional and needle knife sphincterotomy.

Authors:  Andrzej Jamry
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

3.  Early prediction of post-ERCP pancreatitis by post-procedure amylase and lipase levels: A systematic review and meta-analysis.

Authors:  Hemant Goyal; Sonali Sachdeva; Syed Ali Amir Sherazi; Shweta Gupta; Abhilash Perisetti; Aman Ali; Saurabh Chandan; Benjamin Tharian; Neil Sharma; Nirav Thosani
Journal:  Endosc Int Open       Date:  2022-07-15

Review 4.  Serum amylase and lipase and urinary trypsinogen and amylase for diagnosis of acute pancreatitis.

Authors:  Gianluca Rompianesi; Angus Hann; Oluyemi Komolafe; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

5.  Insulin Resistance as a Novel Risk Factor for Post-ERCP Pancreatitis: A Pilot Study.

Authors:  Ali Riza Koksal; Salih Boga; Huseyin Alkim; Mehmet Bayram; Meltem Ergun; Canan Alkim
Journal:  Dig Dis Sci       Date:  2016-03-19       Impact factor: 3.199

6.  Combination of two-hour post-endoscopic retrograde cholangiopancreatography amylase levels and cannulation times is useful for predicting post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Shiro Hayashi; Tsutomu Nishida; Hiromi Shimakoshi; Akiyoshi Shimoda; Takahiro Amano; Aya Sugimoto; Kei Takahashi; Kaori Mukai; Tokuhiro Matsubara; Masashi Yamamoto; Sachiko Nakajima; Koji Fukui; Masami Inada
Journal:  World J Gastrointest Endosc       Date:  2016-12-16

7.  Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis.

Authors:  Ze-Hui Lv; Da-Qing Kou; Shi-Bin Guo
Journal:  BMC Gastroenterol       Date:  2020-04-20       Impact factor: 3.067

8.  Preventive and therapeutic significance of octreotide combined with lansoprazole on post-ERCP pancreatitis and its effect on serum amylase, inflammatory factors and immune function.

Authors:  Zhiliang Chen; Hong Fu; Jianfeng Fang; Jianhui Yang; Xin Zhu; Bingxiang Cheng; Tiannv Ding
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

9.  Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.

Authors:  Yeon Kyung Lee; Min Jae Yang; Soon Sun Kim; Choong Kyun Noh; Hyo Jung Cho; Sun Gyo Lim; Jae Chul Hwang; Byung Moo Yoo; Jin Hong Kim
Journal:  J Korean Med Sci       Date:  2017-11       Impact factor: 2.153

10.  Serum amylase and lipase levels for prediction of postendoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Mohammad Minakari; Vahid Sebghatollahi; Maryam Sattari; Elaheh Fahami
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.